Description

• General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.Insulin Glargine, a peptide produced by recombinant DNA techniques is composed of two chains - the A-chain (21 amino acids) and the B-chain (32 amino acids), making up a total of 53 amino acids. Its primary structure is almost identical to that of Human Insulin, except for the A21 position, where it has Gly instead of Asn. It has two additional amino acids, Arg (B31) and Arg (B32), located at the end of the B-chain. [1]
• Application: Insulin glargine USP reference standard suitable for use in specified USP compendial tests and assays.Also used to prepare standard, standard stock and system suitability solutions for assay by liquid chromatography in conjunction with a UV detector according to the given below monographs of United States Pharmacopeia (USP):Insulin Glargine Injection [2]Insulin Glargine [1]〈121〉 Insulin Assays [3]
• Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​
• Other Notes: This product is part of the USP Biologics program.